452 related articles for article (PubMed ID: 11937530)
1. In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function.
Lang TJ; Nguyen P; Peach R; Gause WC; Via CS
J Immunol; 2002 Apr; 168(8):3786-92. PubMed ID: 11937530
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD.
Via CS; Rus V; Nguyen P; Linsley P; Gause WC
J Immunol; 1996 Nov; 157(9):4258-67. PubMed ID: 8892665
[TBL] [Abstract][Full Text] [Related]
3. Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells.
Blazar BR; Sharpe AH; Taylor PA; Panoskaltsis-Mortari A; Gray GS; Korngold R; Vallera DA
J Immunol; 1996 Oct; 157(8):3250-9. PubMed ID: 8871619
[TBL] [Abstract][Full Text] [Related]
4. T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockade.
Woodward JE; Bayer AL; Chavin KD; Blue ML; Baliga P
Transplantation; 1998 Jul; 66(1):14-20. PubMed ID: 9679816
[TBL] [Abstract][Full Text] [Related]
5. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo.
Yamada A; Salama AD; Sho M; Najafian N; Ito T; Forman JP; Kewalramani R; Sandner S; Harada H; Clarkson MR; Mandelbrot DA; Sharpe AH; Oshima H; Yagita H; Chalasani G; Lakkis FG; Auchincloss H; Sayegh MH
J Immunol; 2005 Feb; 174(3):1357-64. PubMed ID: 15661893
[TBL] [Abstract][Full Text] [Related]
6. Effect of CD80 and CD86 blockade and anti-interleukin-12 treatment on mouse acute graft-versus-host disease.
Saito K; Yagita H; Hashimoto H; Okumura K; Azuma M
Eur J Immunol; 1996 Dec; 26(12):3098-106. PubMed ID: 8977310
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of suboptimal CD8 cytotoxic T cell effector function in vivo using antigen-specific CD80 defective T cells.
Puliaeva I; Soloviova K; Puliaiev M; Lang T; Puliaev R; Via CS
J Immunol; 2011 Jan; 186(1):291-304. PubMed ID: 21115734
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
[TBL] [Abstract][Full Text] [Related]
10. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
Broeren CP; Gray GS; Carreno BM; June CH
J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
[TBL] [Abstract][Full Text] [Related]
11. CTL-Promoting Effects of IL-21 Counteract Murine Lupus in the Parent→F1 Graft-versus-Host Disease Model.
Nguyen V; Rus H; Chen C; Rus V
J Immunol; 2016 Feb; 196(4):1529-40. PubMed ID: 26792801
[TBL] [Abstract][Full Text] [Related]
12. Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway.
Shanafelt MC; Kang I; Barthold SW; Bockenstedt LK
Infect Immun; 1998 Jan; 66(1):266-71. PubMed ID: 9423867
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Vallera DA
J Immunol; 1998 Jun; 160(11):5355-65. PubMed ID: 9605135
[TBL] [Abstract][Full Text] [Related]
14. Modulation of experimental blood stage malaria through blockade of the B7/CD28 T-cell costimulatory pathway.
Taylor-Robinson AW; Smith EC
Immunology; 1999 Mar; 96(3):498-504. PubMed ID: 10233733
[TBL] [Abstract][Full Text] [Related]
15. Requirement of CD28-CD86 co-stimulation in the interaction between antigen-primed T helper type 2 and B cells.
Nakajima A; Watanabe N; Yoshino S; Yagita H; Okumura K; Azuma M
Int Immunol; 1997 May; 9(5):637-44. PubMed ID: 9184909
[TBL] [Abstract][Full Text] [Related]
16. Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ.
Anderson BE; McNiff JM; Jain D; Blazar BR; Shlomchik WD; Shlomchik MJ
Blood; 2005 Mar; 105(5):2227-34. PubMed ID: 15522961
[TBL] [Abstract][Full Text] [Related]
17. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway.
Ossevoort MA; Ringers J; Kuhn EM; Boon L; Lorré K; van den Hout Y; Bruijn JA; de Boer M; Jonker M; de Waele P
Transplantation; 1999 Oct; 68(7):1010-8. PubMed ID: 10532543
[TBL] [Abstract][Full Text] [Related]
18. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
[TBL] [Abstract][Full Text] [Related]
19. Induction of CD4 T cell changes in murine AIDS is dependent on costimulation and involves a dysregulation of homeostasis.
Yen MH; Lepak N; Swain SL
J Immunol; 2002 Jul; 169(2):722-31. PubMed ID: 12097374
[TBL] [Abstract][Full Text] [Related]
20. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]